Personal Genomics Zone

Manuel Corpas

Why does 81% of genomic research exclude most of humanity? Dr. Manuel Corpas examines how genomic diversity--or its absence--shapes the future of precision medicine. Exploring health equity metrics (HEIM), pharmacogenomics, and the global infrastructure needed to make genomic medicine work for everyone, not just a few. Featuring insights on building inclusive genomic research across Latin America, the Middle East, and beyond.

About

Why does 81% of genomic research exclude most of humanity? Dr. Manuel Corpas examines how genomic diversity--or its absence--shapes the future of precision medicine. Exploring health equity metrics (HEIM), pharmacogenomics, and the global infrastructure needed to make genomic medicine work for everyone, not just a few. Featuring insights on building inclusive genomic research across Latin America, the Middle East, and beyond.